Harvard Bioscience News and Activities

Harvard Bioscience is a company listed under the stock ticker HBIO (US).

View the org chart displaying its 16 main executives

Most searched biographies at Harvard Bioscience

• John Duke, President and Chief Executive Officer
• Katherine Eade, Director
• Stephen DeNelsky, Director

Popular executive movements at Harvard Bioscience

• Stephen DeNelsky has joined the company as Director  (posted on September 10 2025).

Create your alert
to follow the executive moves at Harvard Bioscience.

Harvard Bioscience has 1,235 competitors including Thermo Fisher Scientific (United States (USA)), Philips (Netherlands) and Medtronic (Ireland).

Popular M&A news in Medical Equipment

• Niowave has just announced a $70 Million fundraising (posted on June 2 2026).
• The new name of Edap Tms is FocalTherics. (posted on June 1 2026).
• FocalTherics is now listed under ticker FOCL. (posted on May 31 2026).

Popular contacts in Medical Equipment

• Kweli Thompson - Executive Vice President and President, Neuroscience Portfolio at Medtronic
• Jacob Thaysen - Chief Executive Officer and Director at Illumina
• Ivan Tornos - Chairman, President and Chief Executive Officer at Zimmer Biomet

Learn more about the Medical Equipment industry

Press releases by Harvard Bioscience

• Harvard Bioscience Announces First Quarter 2026 Financial Results | Harvard Bioscience, Inc.
• Harvard Bioscience to Participate in Upcoming Investor Conferences | Harvard Bioscience, Inc.
• Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET | Harvard Bioscience, Inc.
• Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results | Harvard Bioscience, Inc.
• Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum | Harvard Bioscience, Inc.
• Harvard Bioscience Announces Reverse Stock Split | Harvard Bioscience, Inc.
• Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET | Harvard Bioscience, Inc.
• Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas | Harvard Bioscience, Inc.
• Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth | Harvard Bioscience, Inc.
• Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package | Harvard Bioscience, Inc.
• View more press releases Close

Social media about Harvard Bioscience

• Harvard Bioscience on Wikipedia, Google News & Yahoo Finance
• Harvard Bioscience on LinkedIn, X (Twitter) & YouTube